Lo-Zumandimine Interactions
There are 596 drugs known to interact with Lo-Zumandimine (drospirenone/ethinyl estradiol), along with 19 disease interactions, and 6 alcohol/food interactions. Of the total drug interactions, 94 are major, 456 are moderate, and 46 are minor.
- View all 596 medications that may interact with Lo-Zumandimine
- View Lo-Zumandimine alcohol/food interactions (6)
- View Lo-Zumandimine disease interactions (19)
Most frequently checked interactions
View interaction reports for Lo-Zumandimine (drospirenone / ethinyl estradiol) and the medicines listed below.
- acetaminophen
- albuterol
- ashwaganda
- azelastine nasal
- bupropion
- buspirone
- cetirizine
- clonidine
- cyclobenzaprine
- doxycycline
- escitalopram
- gabapentin
- hydroxychloroquine
- hydroxyzine
- lamotrigine
- Lexapro (escitalopram)
- lorazepam
- magnesium glycinate
- metformin
- montelukast
- naproxen
- Ozempic (semaglutide)
- pantoprazole
- prednisone
- propranolol
- sertraline
- trazodone
- Vitamin D3 (cholecalciferol)
- Wellbutrin (bupropion)
- Zyrtec (cetirizine)
Lo-Zumandimine alcohol/food interactions
There are 6 alcohol/food interactions with Lo-Zumandimine (drospirenone / ethinyl estradiol).
Lo-Zumandimine disease interactions
There are 19 disease interactions with Lo-Zumandimine (drospirenone / ethinyl estradiol) which include:
- smoking
- hyperkalemia
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
Report options
More about Lo-Zumandimine (drospirenone / ethinyl estradiol)
- Lo-Zumandimine consumer information
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: contraceptives
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.